Isoniazid and rifampin drug susceptibility testing: application of 2,3,5-triphenyl tetrazolium chloride assay and microscopic-observation drug-susceptibility assay directly on Ziehl-Neelsen smear positive sputum specimens-Reference-Cited by-同舟云学术

Isoniazid and rifampin drug susceptibility testing: application of 2,3,5-triphenyl tetrazolium chloride assay and microscopic-observation drug-susceptibility assay directly on Ziehl-Neelsen smear positive sputum specimens

Published:2016-01 Issue:1 Volume:20 Page:33-40
ISSN:1413-8670
Container-title:The Brazilian Journal of Infectious Diseases
language:en
Short-container-title:The Brazilian Journal of Infectious Diseases

Author:

Shinu Pottathil,Singh Varsha,Nair Anroop

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference28 articles.

1. Global tuberculosis report;World Health Organization (WHO),2014

2. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000–2004;Center of Disease Control and Prevention,2006

3. Worldwide emergence of extensively drug-resistant tuberculosis;Shah;Emerg Infect Dis,2007

4. Manual for laboratory technicians [Online];Revised National Tuberculosis Control Programme,2009

5. The Global Plan to Stop TB, 2006–2015. Actions for life: towards a world free of tuberculosis;Stop TB Partnership;Int J Tuberc Lung Dis,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2,3,5-triphenyl tetrazolium chloride as colorimetric indicator for drug susceptibility testing against nontuberculous mycobacteria;Diagnostic Microbiology and Infectious Disease;2024-01

2. Progress Report: Antimicrobial Drug Discovery in the Resistance Era;Pharmaceuticals;2022-03-28

3. A Saudi Arabian Public Health Perspective of Tuberculosis;International Journal of Environmental Research and Public Health;2021-09-24

4. Monitoring of Non-β-Lactam Antibiotic Resistance-Associated Genes in ESBL Producing Enterobacterales Isolates;Antibiotics;2020-12-09

5. Finding New Ways to Combat Multidrug-Resistant Tuberculosis;Microbial Drug Resistance;2020-01-01